UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
August 20, 2026 4:00 P.M.
Form:
S-3
CIK:
0001737287
Company Name:
Allogene Therapeutics, Inc.
File Number:
333-298268